From Monday 4 October, the All Wales Therapeutics and Toxicology Centre (AWTTC) will join established partners, the Medicines and Healthcare products Regulatory Agency (MHRA), the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC) in the Innovative Licensing and Access Pathway (ILAP).
Following agreement by Welsh Ministers, the AWTTC will join these partners in the ILAP activities, including considering if a product meets the criteria for an Innovation Passport. To date, partners have made effective joint decisions and are awarding Innovation Passports to products that will benefit patients.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
